News
Patients are enrolled prospectively at participating sites and treated per local standard of care. HCV-TARGET does not define treatment regimens, dosing, or duration or safety management practices. Source data is the original medical record. All original clinic notes,...
News
Listed below are HCV-TARGET Study Group presentations at the 2013 annual meeting of the American Association for the Study of Liver Diseases. For abstracts, visit http://www.aasld.org/livermeeting. Contact: Joy A. Peter, Project Manager, Joy.Peter@medicine.ufl.edu...
News
WASHINGTON — As doctors prepare to manage an influx of new hepatitis C patients and treatment options, a collaboration among academia, industry and the U.S. Food and Drug Administration is poised to deliver real-world data that can help doctors and patients optimize...
News
AMSTERDAM –– Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...
Recent Comments